For more than 130 years, Abbott has been known as a company that helps people live healthier lives.

In this article, we discuss 12 best medical technology stocks to buy. If you want to read about some more medical technology stocks, go directly to 5 Best Medical Technology Stocks to Buy. The medical technology industry can finally start to put the COVID-19 virus behind it after United States President Joe Biden admitted in […]

Lawmakers said they expected the legislation would make formula easier to find, especially for families in the WIC supplemental-nutrition program.

Bulk orders for COVID-19 tests are on the rise as companies brace for a winter surge.

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

NORTHAMPTON, MA / ACCESSWIRE / September 28, 2022 / Abbott Resilience. It's often defined as the ability to recover quickly from challenges and difficulties. It requires adaptability and is a skill that is especially important for families and communities ...

Abbott (NYSE: ABT) will announce its third-quarter 2022 financial results on Wednesday, Oct. 19, 2022, before the market opens.

Let's talk about two leaders in their markets and a well-diversified healthcare company with a track record of success. Vertex Pharmaceuticals (NASDAQ: VRTX) has been generating returns for investors for quite a while. Vertex is the global market leader in the treatment of cystic fibrosis (CF).

As people acclimatize to the new normal, it’s time to look at some vaccine stocks to sell. Instead of relying primarily on vaccines and antiviral drugs, the government let people manage infections. Once infected with the less fatal strain, Omicron, people would isolate themselves for a few days and then return to work. By shifting away from its reliance on drug companies, investors must recognize there are vaccine stocks that it’s time to sell. The government cut orders for vaccines and antivira